EUVIMEDEUVIMED entdecken
Open Access

Lipoxin A 4 / FPR2 Signaling Mitigates Ferroptosis of Alveolar Epithelial Cells via NRF2 ‐Dependent Pathway During Lung Ischemia–Reperfusion Injury

Denny Joseph Manual Kollareth, Victoria Leroy iD, Zhenxiao Tu, Makena Jade Woolet-Stockton, Manasi Kamat, Timothy J Garrett, Carl Atkinson, Guoshuai Cai, Gilbert R Upchurch, Ashish K Sharma

The FASEB Journal · 2025

DOI: 10.1096/fj.202401475r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Denny Joseph Manual Kollareth und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Lipoxins, NF-E2-Related Factor 2, Ferroptosis, Reperfusion Injury. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, David and Kim Raab Foundation, HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Post‐lung transplant (LTx) injury can involve sterile inflammation due to ischemia–reperfusion injury (IRI) that contributes to allograft dysfunction. In this study, we investigated the cell‐specific role of ferroptosis (excessive iron‐mediated cell death) in mediating lung IRI and investigated if specialized pro‐resolving mediators such as Lipoxin A4 (LxA 4 ) can protect against ferroptosis in lung IRI. Single‐cell RNA sequencing analysis of lung tissue from post‐LTx patients was performed, and lung IRI was evaluated in C57BL/6 (WT), formyl peptide receptor 2 knockout ( Fpr2 −/− ) and nuclear factor erythroid 2‐related factor 2 knockout ( Nrf2 −/− ) mice using a hilar‐ligation model with or without LxA 4 administration. Furthermore, the protective efficacy of LxA 4 was evaluated employing a murine orthotopic LTx model and in vitro studies using alveolar type II epithelial (ATII) cells. The results show differential expression of ferroptosis‐related genes in post‐LTx patient samples compared to healthy controls. A significant increase in the levels of oxidized lipids and a reduction in the levels of intact lipids were observed in mice subjected to IRI compared to shams. Importantly, LxA 4 treatment attenuated pulmonary dysfunction, ferroptosis, and inflammation in WT mice subjected to lung IRI, but not in Fpr2 −/− or Nrf2 −/− mice after IRI. In the murine LTx model, LxA 4 treatment increased PaO 2 levels and attenuated lung IRI. Mechanistically, LxA 4 ‐mediated protection involves an increase in NRF2 activation and glutathione concentration as well as a decrease in MDA levels in ATII cells. In summary, our results collectively show that LxA 4 /FPR2 signaling on ATII cells mitigates ferroptosis via NRF2 activation and protects against lung IRI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipoxinsNF-E2-Related Factor 2FerroptosisReperfusion InjuryReceptors, Formyl PeptideAlveolar Epithelial CellsReceptors, LipoxinAnimalsMiceMice, Inbred C57BLSignal TransductionHumansMice, KnockoutMaleLungLung Transplantation

Stichwörter der Autor:innen

ferroptosisischemia–reperfusion injurylipoxin A4liproxstatin‐1lung transplant

Substanzen

LipoxinsNF-E2-Related Factor 2lipoxin A4Receptors, Formyl PeptideReceptors, LipoxinNfe2l2 protein, mouseFPR2 protein, humanformyl peptide receptor 2, mouseNFE2L2 protein, human

Autor:innen und Institutionen

  • Department of Surgery, University of Florida, Gainesville, Florida, USA.
  • Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Florida, Gainesville, Florida, USA.
  • Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA.
  • Department of Pharmacology and Therapeutics, University of Florida, Gainesville, Florida, USA.

ORCID-Profile: Victoria Leroy

Förderung

  • NHLBI NIH HHS
  • David and Kim Raab Foundation
  • HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Kollareth, D. J. M., Leroy, V., Tu, Z., Woolet-Stockton, M. J., Kamat, M., Garrett, T. J., Atkinson, C., Cai, G., Upchurch, G. R., & Sharma, A. K. (2025). Lipoxin A 4 / FPR2 Signaling Mitigates Ferroptosis of Alveolar Epithelial Cells via NRF2 ‐Dependent Pathway During Lung Ischemia–Reperfusion Injury. The FASEB Journal. https://doi.org/10.1096/fj.202401475r

Vancouver

Kollareth DJM, Leroy V, Tu Z, Woolet-Stockton MJ, Kamat M, Garrett TJ, et al. Lipoxin A 4 / FPR2 Signaling Mitigates Ferroptosis of Alveolar Epithelial Cells via NRF2 ‐Dependent Pathway During Lung Ischemia–Reperfusion Injury. The FASEB Journal. 2025. doi:10.1096/fj.202401475r

BibTeX
@article{Kollareth2025,
  author = {Kollareth, Denny Joseph Manual and Leroy, Victoria and Tu, Zhenxiao and Woolet-Stockton, Makena Jade and Kamat, Manasi and Garrett, Timothy J and Atkinson, Carl and Cai, Guoshuai and Upchurch, Gilbert R and Sharma, Ashish K},
  title = {Lipoxin A 4 / FPR2 Signaling Mitigates Ferroptosis of Alveolar Epithelial Cells via NRF2 ‐Dependent Pathway During Lung Ischemia–Reperfusion Injury},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202401475r}
}
Kostenlos starten →